Suchergebnisse - "Shukarev, Georgi"

PubPharm (28)

1

Thrombosis with thrombocytopenia syndrome : A database review of clinical trial and post-marketing experience with Ad26.COV2.S

enthalten in: Vaccine | 2023

von Struyf, F. | Hardt, K. | Van Rampelbergh, R. | +12

2

Quantifying Antibody Persistence After a Single Dose of COVID-19 Vaccine Ad26.COV2.S in Humans Using a Mechanistic Modeling and Simulation Approach

enthalten in: Clinical pharmacology and therapeutics | 2023

von Dari, A. | Boulton, M. | Neyens, M. | +8

3

Quantifying Antibody Persistence After a Single Dose of COVID‐19 Vaccine Ad26. COV2.S in Humans Using a Mechanistic Modeling and Simulation Approach

enthalten in: Clinical Pharmacology & Therapeutics | 2023

von Dari, A. | Boulton, M. | Neyens, M. | +8

4

Efficacy, safety, and immunogenicity of a booster regimen of Ad26.COV2.S vaccine against COVID-19 (ENSEMBLE2) : results of a randomised, double-blind, placebo-controlled, phase 3 trial

enthalten in: The Lancet. Infectious diseases | 2022

von Hardt, K. | Vandebosch, A. | Sadoff, J. | +115

CommentIn: Lancet Infect Dis. 2022 Dec;22(12):1654-1655. - PMID 36113536

5

Safety and immunogenicity of 3 formulations of a Sabin inactivated poliovirus vaccine produced on the PER.C6® cell line : A phase 2, double-blind, randomized, controlled study in infants vaccinated at 6, 10 and 14 weeks of age

enthalten in: Human vaccines & immunotherapeutics | 2022

von Ong-Lim, A. | Shukarev, G. | Trinidad-Aseron, M. | +10

6

Durable antibody responses elicited by 1 dose of Ad26.COV2.S and substantial increase after boosting : 2 randomized clinical trials

enthalten in: Vaccine | 2022

von Sadoff, J. | Le Gars, M. | Brandenburg, B. | +16

7

Final Analysis of Efficacy and Safety of Single-Dose Ad26.COV2.S

enthalten in: The New England journal of medicine | 2022

von Sadoff, J. | Gray, G. | Vandebosch, A. | +127

8

First-in-human study to evaluate safety, tolerability, and immunogenicity of heterologous regimens using the multivalent filovirus vaccines Ad26.Filo and MVA-BN-Filo administered in different sequences and schedules : A randomized, controlled study

enthalten in: PloS one | 2022

von Bockstal, V. | Shukarev, G. | McLean, C. | +15

9

Safety and immunogenicity of 2-dose heterologous Ad26.ZEBOV, MVA-BN-Filo Ebola vaccination in children and adolescents in Africa : A randomised, placebo-controlled, multicentre Phase II clinical trial

enthalten in: PLoS medicine | 2022

von Anywaine, Z. | Barry, H. | Anzala, O. | +21

10

Assessments of different batches and dose levels of a two-dose Ad26.ZEBOV and MVA-BN-Filo vaccine regimen

enthalten in: NPJ vaccines | 2021

von Bockstal, V. | Gaddah, A. | Goldstein, N. | +7